Harmony Biosciences' (NASDAQ:HRMY)  stock fell about 7.3% after U.S. FDA notified the company that it will not review the ...

Days after Robert F. Kennedy Jr. was sworn in as HHS secretary, health agencies including the FDA, NIH and CDC saw sweeping ...

Discover key insights from Penumbra’s Q4 2024 earnings call: 12.9% revenue growth, strong thrombectomy performance, new product launches & 2025 ...

While the FDA’s diversity guidance for clinical trials has been temporarily restored, the page it is housed on now carries a ...

On January 6, 2025, the US Food and Drug Administration (FDA) published final guidance titled “Communications From Firms to Health Care ...

The Department of Government Efficiency fired the FDA employees who were responsible for overseeing the clinical trial ...

The use of stigmatizing terminology in National Institute on Drug Abuse (NIDA)-funded grant abstracts has decreased by over half since 2013.

Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

The Trump administration had directed health agencies to place a notice condemning “gender ideology” on health webpages that ...

The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...

Every baby food product packaged in jars, pouches, tubs and boxes sold in California must carry a QR code on its label that consumers can scan to check the most recent heavy metal readings, although ...

Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for ...